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Facing current climate challenges and drastically reduced chemical options for plant 
protection, the exploitation of RNA interference (RNAi) as an agricultural biotechnology tool 
has unveiled possible new solutions to the global problems of agricultural losses caused by 
pests and other biotic and abiotic stresses. While the use of RNAi as a tool in agriculture is 
still limited to a few transgenic crops, and only adopted in restricted parts of the world, 
scientists and industry are already seeking innovations in leveraging and exploiting the 
potential of RNAi in the form of RNA-based biocontrol compounds for external applications. 
Here, we highlight the expanding research and development pipeline, commercial landscape 
and regulatory environment surrounding the pursuit of RNA-based biocontrol compounds 
with improved environmental profiles. The commitments of well-established agrochemical 
companies to invest in research endeavours and the role of start-up companies are crucial for 
the successful development of practical applications for these compounds. Additionally, the 
availability of standardized guidelines to tackle regulatory ambiguities surrounding RNA-
based biocontrol compounds will help to facilitate the entire commercialization process. 
Finally, communication to create awareness and public acceptance will be key to the 
deployment of these compounds. 
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1. Introduction to RNAi-based technology 
RNA interference (RNAi)-based technology has proven to be a powerful and precise strategy 
that can be exploited to improve crop production and protection. RNAi is based on natural 
sequence-specific and evolutionarily conserved mechanisms in eukaryotes regulating gene 
expression at the transcriptional or post-transcriptional level, thus providing a natural defence 
system that can target invading nucleic acids of hostile organisms and viruses. Deciphering 
the RNAi mechanisms has provided scientists with the ability to specifically silence target 
genes post-transcriptionally, which could be endogenous plant genes, genes of plant 
pathogens (viruses and fungi) or genes of other plant pests (insects, mites, nematodes and 
weeds).1 By using different types of RNAi triggers, such as hairpin-structured RNAs 
(hpRNAs), artificial microRNAs (amiRNAs) and/or double-stranded RNAs (dsRNAs), the 
function of these targets can be blocked. Post-transcriptional RNAi mechanisms explore a 
sequence-dependent mode of action at the mRNA level to prevent the translation of the 
targeted mRNA into proteins by mRNA degradation or translational repression, hence leading 
to target gene silencing and subsequently the desired effect.2,3 This sequence-dependent mode 
of action makes RNAi unique in selectivity and efficiency compared to other conventional 
agrochemicals. Products using the RNAi mode of action can be designed to selectively target 
the expression of specific genes or groups of similar gene sequences, in a targeted species for 
which they are developed while leaving other non-target organisms unaffected. As such, 
RNAi has gained remarkable prominence among researchers as a strategy of choice for 
improving crop yield, for generating plants with novel traits (PNTs), for post-harvest 
protection and for managing weeds, other pests and diseases caused by bacteria, fungi and 




2. RNA-based biocontrol compounds for external application 
In the context of field application, the RNAi approach for crop protection can be applied in 
planta via the production of a genetically modified (GM) crop in which host-induced gene 
silencing (HIGS) can be accomplished by stably integrating RNAi-based constructs designed 
against one or multiple target sequences. Alternatively, an RNAi strategy can be employed via 
the exogenous application of a formulated product with dsRNA as the active ingredient by 
itself, through a modified virus (virus induced gene silencing), modified bacteria (live or 
inactivated) or through modified fungi.4 An increasing number of in planta RNAi-based 
events have been developed, risk-assessed, and have received approval by international 
regulatory agencies in different countries.5 These events encompass a wide variety of plant 
species from maize to potato as well as a range of traits including virus resistance, pest 
resistance and plant composition modification. However, the difficulty in genetic 
transformation of some crop species, expensive capital requirements and political/public 
concerns surrounding the cultivation and use of GM crops6 has favoured the need to develop 
sprayable dsRNA‐containing end‐ use products (dsRNA -EPs). Spray-induced gene silencing 
(SIGS) and other exogenous applications (such as root or seed soaking, trunk injection, 
petiole absorption and mechanical inoculation)1,4 as alternatives to the GM plant approach, 
silence target genes in a target organism without introducing heritable changes in the genome, 
hence do not fall within the restrictions currently defined by the EU regulation on GMOs. 
This of course excludes the scenario where the final product containing the dsRNA active 
ingredient is a GMO, as is the case when microbes are engineered to produce specific 




Several studies have demonstrated that dsRNAs applied exogenously on plant tissues 
can induce RNAi-mediated silencing of targeted pest or pathogen genes. Examples include 
the induction of plant resistance to fungi, insects and viruses, following external application of 
bacterially produced or in vitro synthesized long dsRNAs, hpRNAs, or small interfering 
RNAs (siRNAs), designed to selectively target essential genes of pests and pathogens.7,8 
Some studies have also shown that topically applied dsRNAs can act on both the treated plant 
area as well as on distal non-treated parts by systemic translocation of dsRNAs via the plant 
vascular system, following application via mechanical wounding.9,10,11 These results 
demonstrate the possibility of active uptake of exogenously applied dsRNAs by plant cells 
and their processing into siRNAs, which should extend the time of control/prevention against 
some plant diseases. However, specific features of the target organism (i.e., RNAi machinery, 
structural characteristics, host-pathogen interaction mechanisms) can influence the efficacy of 
such RNAi-based strategies. It has been demonstrated for example that the absence of 
secondary siRNA amplification or the lack of dsRNA uptake by the target pathogen, limits the 
application of exogenous RNAi approaches against specific fungi.12,13 Furthermore, the 
delivery method chosen for dsRNA molecules (i.e. by mechanical inoculation or leaf 
spraying) represents another crucial point that influences the effectiveness of exogenous 
RNAi-based strategies, and that should be selected on the basis of the plant type and on the 
type of pest species targeted.14 Efficient delivery methods have been described in several 
reports on the down-regulation of plant endogenes and transgenes by the external application 
of either naked dsRNAs, dsRNAs protected by liposome, artificial extracellular vesicles (EV), 
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or complexed with nanoparticles or a protein carrier.15-19 Nanocarriers are increasingly being 
used as effective translational tools in achieving commercial viability of sprayable RNA-
based biocontrol compounds.20 As such, the combination of RNAi technology and 
nanotechnology is perceived as a game changer in the crop protection industry.21 An example 
is the use of “layered double hydroxide clay nanoparticles” (BioClay) to deliver dsRNA as a 
stable application with increased longevity, highlighting the significance of nanoparticles as 
delivery vehicles, and the progress towards translation from the lab to the field.22 This will 
however be dependent on the cost of production and efficiency of the developed nanocarriers. 
Recently, the use of DNA nanostructures serving as RNA carriers through Watson-Crick base 
pairing has been reported to be an efficient tool for delivery of siRNA into plant cells.23 
However, parameters such as the compactness, stiffness, size, shape and location of the 
siRNA attachment locus on the nanostructure will have to be taken into consideration during 
formulation in order to assure proper internalization of the nanostructure into plant cells for a 
corresponding good gene silencing efficiency. Although RNA-based biocontrol compounds 
are still in the R&D pipeline, they are broadly anticipated to fall under the following 
categories; direct control agents, resistance factor repressors, developmental disruptors and 
growth enhancers.24 Additionally, these biocontrol products will likely be applied both 
outdoor on field crops and indoors in green houses using already available delivery systems in 
agriculture. 
3. Commercial environment for RNA-based biocontrol compounds 
The analysis of this specific innovation sector reveals that RNAi-based biocontrol is an 
emerging technology endowed with a positive patenting trend over time and promising future 
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applications and development.25 As for the type of applicant involved in this specific 
innovation cluster, it can be said that globally almost 50% of the total patent activity derives 
from public R&D, principally from US and Chinese applicants. As for the private sector, 
agbiotech companies are still the major players in patent production, but the sector was 
characterized by a greater concentration in the early years of development, while recently a 
larger number of small-medium players have become involved in this research area.26 It is 
evident that commercial interest towards sprayable RNA-based compounds in agriculture has 
significantly increased considering recent investments in R&D for RNA co-formulants. The 
initiated pipeline branded “BioDirect” by Monsanto is developing RNA-based compounds to 
control insect pests (Colorado potato beetle, Brassica flea beetle and Varroa mites), pathogens 
(Tospovirus) and glyphosate resistant weeds.27,28 Bayer CropScience (who acquired 
Monsanto)29 is also joining the race towards the development of the first RNA-based 
compounds in agriculture. Another multinational company, Syngenta (ChemChina), who 
acquired the Belgian firm Devgen brought in the latter’s technical expertise to develop RNA-
based applications against various above and below ground insect pests.30 The commercial 
interest for RNA applications by these large companies has stimulated the development of 
start-up companies that exploit existing or emerging biotechnology tools to create the needed 
platforms and technologies for the agribusiness. Examples include technologies for mass 
production of dsRNA at low cost by companies such as GreenLight Biosciences, RNAgri 
(former APSE) and AgroRNA (Genolution). GreenLight Biosciences has successfully 
developed a distinctive cell-free bioprocessing platform capable of producing RNA sequences 
in a fully-scalable fashion at a low cost of $0.5/g compared to fermentation ($1/g), in vitro 
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transcription ($1000/g) and chemical synthesis ($100,000/g) platforms.31 Considering that for 
field application, dsRNA should be available in large quantities and in a cost-effective 
manner, it does not necessarily have to be as pure as for medical application and the source of 
the dsRNA should entail no GMO concerns (if produced using a GMO), AgroRNA has 
developed an effective procedure for synthesizing dsRNA (200 to 800 bp) of mg to kg scale 
through a fermentation platform (http://www.agrorna.com/). A significant decrease in the cost 
price of dsRNA over the last decade (from $12,500/g in 2008) has significantly enhanced the 
feasibility of applying RNA-based compounds at field scales in a cost-effective manner. 
However, it is worth noting that naked dsRNA will have to be formulated for protection 
against degradation and for improved delivery to the target prior to application in crop 
protection. To achieve this, the start-up company AgroSpheres has developed a proprietary 
bioparticle platform consisting of small, spherical cells lacking chromosomes, that can 
encapsulate dsRNA thereby enhancing its delivery for crop protection 
(https://www.agrospheres.com/). In a recent research collaboration with GreenLight, 
AgroSpheres intends to study the delivery of dsRNA produced by GreenLight using its 
proprietary bioparticle platform. This bioparticle can shield the dsRNA active molecule from 
nucleolytic enzymes (RNAses) and from UV radiation in the environment that would 
otherwise destroy the dsRNA. The enormous potential of AgroSpheres’ Minicell platform has 
recently led to the company raising $4 million in a Series A financing round led by the 
venture capital firm Ospraie Ag Science. This Series A financing will fund the development 
and commercialization of AgroSpheres’ core Minicell technology. The biotech company 
RNAagri has also developed a technology that uses a protein to bind the RNA as it is 
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produced thereby protecting it from degradation, allowing subsequent isolation and 
purification (https://www.rnagri.com/). Using large scale fermentation processes these 
protein-protected and ready-to-spray dsRNAs are also produced at costs near $1/g and there is 
interest in exploiting the protein bound to the dsRNA to improve delivery. In pursuit of 
achieving dsRNA stability against degradation and improved delivery to their targets, the 
biotech start-up Nanosur has developed a proprietary platform to produce modified RNA 
(MdsRNA) formulations with improved translocation across cellular membranes, preventing 
rapid degradation and hence improving the efficacy of the RNA-based biopesticide 
(http://www.nanosur.com/). Similarly, the start-up company TrilliumAg has developed a 
novel biological platform for agriculture known as Agrisome, where modified RNA 
molecules known as MV-RNA are self-assembled into protein-based nanoparticles to improve 
delivery and stability (http://www.trilliumag.com/). 
Although these RNA-based biocontrol compounds will probably be more expensive 
than conventional products, their adoption by farmers will likely be linked to their selective 
mode of action and better biosafety profiles compared to conventional products. Furthermore, 
these biocontrol compounds are expected to fit synergistically into existing integrated pest 
management (IPM) strategies designed to protect agricultural crops from economic damage 
by plant pathogens, weeds, pests and other harmful organisms, while reducing reliance on 
hazardous conventional control products. Organic agriculture could also benefit from these 
new natural molecules, particularly in horticultural production, where the permitted 
biopesticides have strong limitations in pest/disease control. Additionally, seminal studies 
have suggested that the exploitation of exogenous RNAi-based compounds for biocontrol 
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could have increased public acceptance, given the fact that this technology does not require 
the genetic modification of crops.32,33  
4. Regulatory guidelines for RNA-based biocontrol compounds 
As with any new emerging technology, developed RNA-based biocontrol compounds will 
have to be approved by the regulatory frameworks existing in different countries. Biosafety 
studies, prior to the approval of these products, especially tailored to confirm the predicted 
selectivity of dsRNA, can reliably be conducted according to the existing risk assessment 
approaches, taking into the account the novel mode of action of these products.34 For RNA-
based biocontrol compounds where additional research might be necessary for risk 
assessments, it will be necessary to first envisage a plausible pathway to harm whereby non-
target organisms (NTOs) might be exposed to the compound, eventually leading to an adverse 
effect to the environment. The pathway to harm should explain how the deployment of the 
RNA-based biocontrol product could lead to adverse impacts on NTOs through a chain of 
events that take into account both hazard and exposure. In the context of crop protection, the 
NTOs must first be exposed to the dsRNA active molecule and first exposure will most often 
occur through the oral route (directly or indirectly via food chains). This will be dependent on 
the persistence of dsRNA in the environment (ability to resist degradation) at high enough 
quantities to be taken up by the NTO and at sufficient amounts to activate the endogenous 
RNAi machinery of the NTO. Once the RNAi machinery of the NTO is activated, it must lead 
to the translational suppression or degradation of the corresponding mRNA in a sequence-
dependent manner. The loss of the targeted transcript should eventually have an adverse effect 
on the NTO. If the likelihood of any of the steps in the pathway to harm is experimentally 
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proven to be impossible or unlikely, then the risk of the RNA-based biocontrol compound to 
the NTO can be considered negligible. Sequence-independent effects on the NTO following 
exposure to non-specific dsRNA has also been hypothesized to potentially affect the NTO.35 
This includes immune stimulation or saturation of the enzymes involved in the RNAi 
machinery, which could in turn negatively affect the fitness of the NTO. The likelihood of this 
occurring in the NTO will probably be low considering the multiple barriers in the pathway to 
harm. Nevertheless, this is also taken into account during risk assessment when the 
probability of lethal and sub lethal effects in the NTOs is evaluated. Another layer of 
complexity to be taken into account during the risk assessment of RNA-based biocontrol 
compounds will be the type of formulations used to improve persistence and delivery to 
targets. Protecting the dsRNA from degradation in the environment and further enhancing 
uptake into cells might increase risks to NTOs by overcoming natural barriers such as the 
presence of nucleases and difficult cellular uptake and release mechanisms which could have 
otherwise protected the NTO. Additionally, the dose of dsRNA taken up by the NTO is 
expected to be higher when exposed to the formulated dsRNA compared with exposure to the 
naked dsRNA, considering the longer persistence of the protected dsRNA molecules in the 
environment. Thus, the level of exposure of NTOs will be influenced by the persistence of the 
dsRNA as well as the routes of exposure. 
Discussions on the risk assessment of RNA-based biopesticides are ongoing. In 2013, 
a framework for the risk assessment of RNA-based pesticides was presented by the USA EPA 
in a white paper submitted to the Federal Insecticide, Fungicide, and Rodenticide Act 
(FIFRA) Science Advisory Panel.24 FIFRA responded to this document by organising a 
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meeting the following year that explicitly addressed several concerns pertaining to ecological 
risk considerations and human health considerations and provided various recommendations 
to address uncertainties related to these concerns.36 A similar exercise was conducted by the 
European Food Safety Authority (EFSA) which triggered the collection of literature reviews 
based on scientific information of RNAi studies.37-39 These reviews, intended to support the 
risk assessment of RNAi-based GM plants, provide a comprehensive overview of RNAi and 
will also be useful in the development of regulatory guidelines for externally applied RNA-
based biocontrol compounds. With a similar objective, an OECD conference on RNA-based 
pesticides was recently organised in April 2019 in Paris, with the aim of providing an 
overview on the current status and future possibilities for the regulation of externally applied 
dsRNA-based compounds. This event provided both inputs and recommendations supporting 
the development of guidance document(s) by the OECD expert group on RNAi-based 
pesticides as practical tool(s) for policy makers and regulators of pesticides all over the world. 
Nevertheless, there remains a need for clear regulatory guidelines for RNA-based biocontrol 
compounds if the technology deployment is to be assured. By advocating for a biopesticide 
approach for RNA-based biocontrol compounds, substantial time and money will be saved in 
the registration of these new biomolecules. This takes into consideration the comparably low 
cost of about US$3–7 million to develop a biopesticide and the short time of approximately 
4 years or less to get into market in the USA, in contrast to more than US$280 million and 
nearly 12 years required to develop one new synthetic pesticide.40,41 
5. Importance of good communication for the acceptance of new biotech products 
In matters relating to biotechnology and biosafety, particularly for biotech products such as 
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RNA-based biopesticides, a good and clear communication is not only important to reassure 
stakeholders but also to ensure and assist with regulatory compliance. Concerns by farmers, 
consumers and other players in the food production chain indicate that it is important to 
engage in dialogues with different stakeholders using a range of approaches and information. 
Lessons drawn from debates on the acceptance of GM crops indicate that while consumers 
can positively influence the acceptance and introduction of a biotech product, awareness and 
proper understanding are required, which is usually a neglected issue. Farmers on the other 
hand are more experienced with novel crop protection products and can influence the choice 
of new products that are to be used on their fields. Thus, both consumers and farmers need to 
be engaged with, by both the industry and researchers. Scientists can play a key role in the 
processes of dialogue and creating awareness amongst stakeholders. The engagement of 
different stakeholders to find a consensus which is realistic, practical and can meet high 
scientific standards, is important prior to meeting legislators. Such engagements could include 
discussions over environmental and food safety, and how to ensure that the development of 
these new technologies for crop protection are appropriately regulated. It should be 
emphasised that the goal is to develop scientific evidence-based and appropriate legislation to 
enable these new tools for crop protection to be introduced into sustainable farming systems.  
6. Conclusions 
Several factors such as reductions in farmland, climate change, population growth, strict 
regulations on current chemical pesticides and scepticism over the safety of GM plants has 
promoted the development of new environmentally friendly approaches to control/manage 
plant pests and diseases and to improve plant traits. The exogenous application of dsRNA for 
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crop protection holds an alluring promise to address these societal concerns and needs. 
However, going forward, the commitment of agribusinesses to invest in research endeavours 
and the role of start-up companies will be crucial to the successful development of practical 
applications of RNA-based biocontrol compounds. Additionally, though the current 
regulations on pesticides can be applied to RNA-based biocontrol products, more appropriate 
and standardized regulatory guidelines are urgently needed to facilitate the entire 
commercialization process. Finally, communication to create awareness and public 
acceptance will be key to the deployment of these compounds. 
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